18 May 2012 11:57
Results of Annual General Meeting
London, UK, 18 May 2012: At the Annual General Meeting of Ark Therapeutics Group plc (LSE: AKT) held yesterday all resolutions were passed. A summary of the proxy voting will be published in the Investor Relations section of the Company's website at www.arktherapeutics.com
A copy of the approved resolutions will be submitted to the National Storage Mechanism and will shortly be available for inspection at: www.hemscott.com/nsm.do
Due to statutory time limits on notice periods for shareholder meetings, it was not possible for shareholder approval to be sought to ratify Dr Venables' appointment at yesterday's AGM. As a result, Dr David Venables, Ark's newly appointed Executive Director - Manufacturing Services, stood down as a Director at yesterday's AGM but was immediately re-appointed as a Director by the Board. His re-appointment will be put to shareholders at the Company's AGM to be held in 2013.
Enquiries:
Ark Therapeutics Group plc | |
Dr Edward Bliss, Company Secretary | +44 (0)20 7388 7722 |